Funder: CMT Research Foundation
Due Dates: Due Dates (Anticipated): Not yet announced
Funding Amounts: Indirect costs up to 10%; funding is milestone-gated
Summary: Supports research leading toward therapeutics for all types of Charcot-Marie-Tooth disease.
Key Information: Funding requires potential return on investment if resulting intellectual property becomes commercially profitable.
Description
The CMT Research Foundation (CMTRF) funds promising research aimed at delivering treatments and cures for all types of Charcot-Marie-Tooth disease (CMT). The foundation focuses primarily on translational research, while also supporting discovery-stage work with a clear link to accelerating therapeutic development. It prioritizes projects with the highest likelihood of advancing toward clinical trials and approved treatments in the near term.
The program is open to researchers and clinicians worldwide, including those working in academic, nonprofit, and for-profit research settings. Funding decisions are guided by CMTRF’s research priorities and Scientific Advisory Board review. Researchers with other interesting approaches relevant to the foundation’s mission are also encouraged to contact CMTRF.
